PuraStat as secondary therapy for hemostasis in Mallory−Weiss syndrome with oral antithrombotic medication
2024

Using PuraStat for Bleeding in Mallory-Weiss Syndrome

publication Evidence: low

Author Information

Author(s): Higashino Makoto, Murakami Hidehiro, Hirata Tetsu, Miyaoka Hiroaki

Primary Institution: Saiseikai Matsuyama Hospital, Ehime, Japan

Hypothesis

Can PuraStat effectively achieve hemostasis in patients with Mallory-Weiss syndrome who are on antithrombotic medication?

Conclusion

PuraStat can achieve complete hemostasis in Mallory-Weiss syndrome when traditional methods fail.

Supporting Evidence

  • PuraStat has been used successfully in gastrointestinal bleeding cases.
  • Endoscopic hemostasis is commonly achieved using clips or band ligation.
  • This is the first report of PuraStat's use in Mallory-Weiss syndrome.

Takeaway

If someone is bleeding in their stomach because of vomiting, PuraStat can help stop the bleeding when other methods don't work.

Methodology

A case report of a 67-year-old man treated with PuraStat after traditional methods failed to stop bleeding.

Limitations

This is a single case report, so broader conclusions cannot be drawn.

Participant Demographics

67-year-old man with a history of coronary artery bypass grafting and on clopidogrel.

Digital Object Identifier (DOI)

10.1002/deo2.70033

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication